Skip to main content

Table 1 Basic information of the two groups

From: Characteristics of coronary arterial lesions in patients with coronary heart disease and hypertension

Group

Disease type [n (%)]

Cardiac dysfunction level III–IV [n(%)]

LVEF (%)

SAP

UAP

STEMI

NSTEMI

UACHD

A (n = 306)

20 (6.5)

180 (58.8)

58 (19.0)

18 (5.9)

30 (9.8)

38 (12.4)

59.91 ± 8.63

B (n = 156)

10 (6.4)

90 (57.7)

42 (26.9)

8 (5.1)

6 (3.8)

16 (10.3)

60.32 ± 9.39

t/χ 2

     

1.681

1.854

Group

Previous history [n (%)]

LDL-C (mmol/L)

Fasting blood glucose (mmol/L)

eGFR [ml/(min 1.73 m2)]

MI

Previous PCI

Old cerebral infarction

A (n = 306)

26 (8.5)

12 (3.9)

42 (13.7)

2.73 ± 1.07

6.25 ± 1.86

92.37 ± 19.38

B (n = 156)

6 (3.8)

6 (3.8)

12 (7.7)

2.68 ± 1.13

6.27 ± 2.01

92.20 ± 20.29

t/χ 2

3.466

0.002

3.644

0.557

0.088

0.279

Group

Age

Male [n (%)]

Other complications [n(%)]

Family history [(%)]

Smoking [n(%)]

Diabetics

Hyperlipidemia

A (n = 306)

69.6 ± 10.6

164 (53.6)

82 (26.8)

124 (40.5)

94 (30.7)

122 (39.9)

B (n = 156)

69.5 ± 10.6

108 (69.2)a

34 (21.8)

62 (39.7)

24 (15.4)a

68 (43.6)

t/χ 2

0.307

8.265

2.302

0.031

14.439

0.591

Group

blood pressure levels

Medications

Statin

ACEI or ARB

anti-platelet agents

A (n = 306)

149.3 ± 21.1

65 (21.2)

112 (36.6)

19 (55.2)

B (n = 156)

129.0 ± 12.4a

31 (19.8)

11 (7.1)a

77 (49.4)

t/χ 2

11.039

0.118

46.185

1.430

  1. A: CHD-H group; B: CHD group
  2. SAP stable angina pectoris, UAP unstable angina pectoris, UACHD untypical or asymptomatic CHD, OMI old myocardial infarction, STEMI acute ST-elevated myocardial infarction, NSTEMI non-ST-elevation acute myocardial infarction, LVEF left ventricular ejection fraction, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, PCI percutaneous coronary within intervention
  3. Compared with group A, a P < 0.01